- Home
- LFCR
LFCR
Lifecore Biomedical Inc.
as 05-09-2025 4:00pm EST
| Founded: | 1986 | Country: | United States |
| Employees: | N/A | City: | CHASKA |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $8.00 | AVG Volume (30 days): | 208.5K |
| Analyst Decision: | Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.49 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.68 - $7.99 | Next Earning Date: | 04-03-2025 |
| Revenue: | $130,309,000 | Revenue Growth: | 7.23% |
| Revenue Growth (this year): | 1.57% | Revenue Growth (next year): | 3.98% |
Stock Insider Trading Activity of Lifecore Biomedical Inc. (LFCR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| English Aron R. | LFCR | 10% Owner | May 5 '25 | Sell | $7.05 | 41,091 | $289,869.36 | 1,730,618 |
Latest Lifecore Biomedical Inc. News
LFCR Breaking Stock News: Dive into LFCR Ticker-Specific Updates for Smart Investing
Simply Wall St.
7 days ago
Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) hedge funds shareholders had a great week as one-year returns increased after a 11% gain last week
GlobeNewswire
18 days ago
Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference
GlobeNewswire
23 days ago
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
a month ago
Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer
TipRanks
a month ago
China announces retaliatory tariffs, U.S. unemployment rises: Morning Buzz
Simply Wall St.
a month ago
Lifecore Biomedical Third Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
MT Newswires
a month ago
Top Midday Decliners
Thomson Reuters StreetEvents
a month ago
Q3 2025 Lifecore Biomedical Inc Earnings Call
Compare LFCR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LFCR Lifecore Biomedical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.